Text size :

Perrone (Aiom Foundation): “Independent clinical research in crisis in Italy, concrete interventions are needed”

ADNKRONOS

November 15, 2026

Rome, Nov 15. (Adnkronos Health) – Independent clinical research “represents a fundamental resource for advancing scientific knowledge, improving treatments, and offering new opportunities to patients. Yet, in Italy, this sector is going through a difficult phase and needs concrete interventions to become fully competitive again.” This was emphasized by Francesco Perrone, president of the Aiom Foundation, who spoke at the XXVIII national congress of the Italian Association of Medical Oncology, which concludes today in Rome.

“Independent research is capable of producing advancements in knowledge and improving how we treat our patients. It can also represent a powerful tool for institutions, helping them to govern scientific progress and ensure its sustainability. Unfortunately, however, in Italy it is in crisis. For this reason, we must all make great efforts to make it more efficient,” states Perrone. Among the priorities indicated by the president of the Aiom Foundation is the need to “simplify procedures and remove bureaucratic obstacles that slow down the implementation of clinical studies. A concrete example concerns the possibility of using, also in the context of research, drugs already reimbursed by the National Health Service for normal clinical practice,” when important scientific questions are to be addressed. “We ask institutions for simplifications. I am thinking, for example, of the possibility of using drugs already reimbursed for clinical practice also within clinical studies that address important scientific questions. Measures of this type would allow us to work together more effectively and efficiently. The entire Italian System would benefit,” Perrone emphasizes.

During the congress, several examples of independent research carried out by Italian oncologists were presented, often thanks to great determination and ability to overcome difficulties. Among these, Perrone cites the Fata study, “considered a virtuous model of collaboration between institutions and academia. Funded through Aifa’s first call for proposals, Fata represents the largest completely independent randomized study conducted in the field of breast tumors. The results highlighted an unexpected element: the three aromatase inhibitors used in the treatment do not seem to be entirely equivalent to each other.” “It is a surprising result, which sends us an important message: we must not take anything for granted. Scientific hypotheses must be verified, especially when they concern decisions that directly affect clinical practice. And this is precisely one of the fundamental tasks of independent research,” he concludes.

Jiji Press

Related

Page TOP